- Home
- NEGG vs ENGN Comparison
NEGG vs ENGN Comparison
Compare NEGG & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEGG
- ENGN
- Stock Information
- Founded
- NEGG 2001
- ENGN 1999
- Country
- NEGG United States
- ENGN Canada
- Employees
- NEGG N/A
- ENGN N/A
- Industry
- NEGG Other Specialty Stores
- ENGN
- Sector
- NEGG Consumer Discretionary
- ENGN
- Exchange
- NEGG Nasdaq
- ENGN Nasdaq
- Market Cap
- NEGG 122.3M
- ENGN 204.3M
- IPO Year
- NEGG 2010
- ENGN N/A
- Fundamental
- Price
- NEGG $20.18
- ENGN $3.95
- Analyst Decision
- NEGG
- ENGN Buy
- Analyst Count
- NEGG 0
- ENGN 7
- Target Price
- NEGG N/A
- ENGN $23.29
- AVG Volume (30 Days)
- NEGG 703.0K
- ENGN 98.2K
- Earning Date
- NEGG 08-28-2025
- ENGN 06-12-2025
- Dividend Yield
- NEGG N/A
- ENGN N/A
- EPS Growth
- NEGG N/A
- ENGN N/A
- EPS
- NEGG N/A
- ENGN N/A
- Revenue
- NEGG $1,235,576,000.00
- ENGN N/A
- Revenue This Year
- NEGG N/A
- ENGN N/A
- Revenue Next Year
- NEGG N/A
- ENGN N/A
- P/E Ratio
- NEGG N/A
- ENGN N/A
- Revenue Growth
- NEGG N/A
- ENGN N/A
- 52 Week Low
- NEGG $3.32
- ENGN $2.65
- 52 Week High
- NEGG $26.20
- ENGN $11.00
- Technical
- Relative Strength Index (RSI)
- NEGG 74.63
- ENGN 61.82
- Support Level
- NEGG $15.31
- ENGN $2.95
- Resistance Level
- NEGG $17.52
- ENGN $3.98
- Average True Range (ATR)
- NEGG 2.02
- ENGN 0.25
- MACD
- NEGG 0.54
- ENGN 0.08
- Stochastic Oscillator
- NEGG 98.91
- ENGN 97.14
About NEGG Newegg Commerce Inc.
Newegg Commerce Inc is an e-commerce company offering direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home, and gaming products and provides certain third-party logistics services globally. Geographically, it operates in United States, Canada, and Rest of World.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.